• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INGENIO; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INGENIO; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number J177
Device Problems Premature Discharge of Battery (1057); Battery Problem (2885); Data Problem (3196)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/23/2022
Event Type  Injury  
Event Description
It was reported that this pacemaker showed a decrease in the remining longevity, from five years remining at the previous follow up six months ago to three years remining currently.Premature battery depletion was suspected.It was also noted that the device showed 100% atrial fibrillation (af) and 1553.4 days in af, but this was not accurate for the patient's condition.Device data was submitted to technical services for review.Engineering review confirmed the battery appeared to be depleting faster than expected and device replacement was recommended for within 90 days.Technical services also discussed the erroneous af data was due to a single bit error, which caused the arrhythmia duration value to be corrupted.This did not affect device function.It was noted the physician planned to see the patient again in 90 days to discuss replacement.No adverse patient effects were reported.The device remains implanted and in service.
 
Manufacturer Narrative
This report will be updated when additional information is received.
 
Manufacturer Narrative
This report will be updated when additional information is received.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that this pacemaker showed a decrease in the remining longevity, from five years remining at the previous follow up six months ago to three years remining currently.Premature battery depletion was suspected.It was also noted that the device showed 100% atrial fibrillation (af) and 1553.4 days in af, but this was not accurate for the patient's condition.Device data was submitted to technical services for review.Engineering review confirmed the battery appeared to be depleting faster than expected and device replacement was recommended for within 90 days.Technical services also discussed the erroneous af data was due to a single bit error, which caused the arrhythmia duration value to be corrupted.This did not affect device function.It was noted the physician planned to see the patient again in 90 days to discuss replacement.Additional information was received.The physician decided to continue monitoring this device and the next follow up was planned for 30-august-2023.No adverse patient effects were reported.The device remains implanted and in service.
 
Manufacturer Narrative
This report will be updated when additional information is received.If pertinent information is provided in the future, a supplemental report will be submitted.The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this pacemaker showed a decrease in the remaining longevity, from five years remaining at the previous follow up six months ago to three years remaining currently.Premature battery depletion was suspected.It was also noted that the device showed 100% atrial fibrillation (af) and 1553.4 days in af, but this was not accurate for the patient's condition.Device data was submitted to technical services for review.Engineering review confirmed the battery appeared to be depleting faster than expected and device replacement was recommended for within 90 days.Technical services also discussed the erroneous af data was due to a single bit error, which caused the arrhythmia duration value to be corrupted.This did not affect device function.It was noted the physician planned to see the patient again in 90 days to discuss replacement.Additional information was received.The physician decided to continue monitoring this device and the next follow up was planned for (b)(6) 2023.No adverse patient effects were reported.The device remains implanted and in service.It was later reported that the device was explanted and replaced on (b)(6) 2023.No additional adverse patient effects were reported.The explanted device was returned for analysis.
 
Manufacturer Narrative
This report will be updated when additional information is received.If pertinent information is provided in the future, a supplemental report will be submitted.The product has been received for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, this device was thoroughly analyzed.Longevity calculations were performed, and an increased rate of power consumption was confirmed.Analysis confirmed this device appeared to be exhibiting behavior consistent with a high current condition associated with the pacemaker's low voltage capacitors.This high current condition depleted the devices battery faster than normal.Data analysis determined a single bit error in the device memory had caused the erroneous information in the atrial fibrillation counters; this is diagnostic data only and does not affect device operation.
 
Event Description
It was reported that this pacemaker showed a decrease in the remining longevity, from five years remining at the previous follow up six months ago to three years remining currently.Premature battery depletion was suspected.It was also noted that the device showed 100% atrial fibrillation (af) and 1553.4 days in af, but this was not accurate for the patient's condition.Device data was submitted to technical services for review.Engineering review confirmed the battery appeared to be depleting faster than expected and device replacement was recommended for within 90 days.Technical services also discussed the erroneous af data was due to a single bit error, which caused the arrhythmia duration value to be corrupted.This did not affect device function.It was noted the physician planned to see the patient again in 90 days to discuss replacement.Additional information was received.The physician decided to continue monitoring this device and the next follow up was planned for (b)(6) 2023.No adverse patient effects were reported.The device remains implanted and in service.It was later reported that the device was explanted and replaced on (b)(6) 2023.No additional adverse patient effects were reported.The explanted device was returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INGENIO
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15990941
MDR Text Key306244300
Report Number2124215-2022-52994
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Reporter Country CodeHK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/11/2016
Device Model NumberJ177
Device Catalogue NumberJ177
Device Lot Number483988
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/23/2022
Initial Date FDA Received12/15/2022
Supplement Dates Manufacturer Received03/28/2023
09/15/2023
12/27/2023
Supplement Dates FDA Received04/17/2023
10/10/2023
01/17/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/11/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age84 YR
-
-